Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2025 ASCO Annual Meeting
2025 ASBrS Annual Meeting
ESTRO 2025
DDW 2025
2025 AACR Annual Meeting
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
ASCO Annual Meeting
«
1
»
Advertisement
Advertisement
May
31
Today In Oncology
Sacituzumab Govitecan and Pembrolizumab Improve Disease Control in Advanced PD-L1-Positive TNBC
Vepdegestrant Improves PFS in Select Patients With ESR1-Mutant Advanced Breast Cancer
Impact of Wildfire Related Pollution on Survival in NSCLC
Trastuzumab Deruxtecan Improves Survival Outcomes in Patients With HER2-Positive Gastric-GEJ Cancer
Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy
View More
Advertisement
